demonstrated ICAM1-specific CAR-T cells could recognize ICAM-1 expressing breast cancer cells and inhibit tumor growth in vitro and in vivo (93), which provided a reference for CAR-T cell therapy in CRC. This evidence concerns the gene ICAM1 and colorectal carcinoma.